Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Vismodegib 150 MG Oral Capsule
Locations
1
United States
Moffitt Cancer Center
Tampa, Florida, United States
Start Date
March 23, 2023
Primary Completion Date
December 1, 2028
Completion Date
December 1, 2029
Last Updated
April 1, 2026
NCT05969860
NCT04806646
NCT01835626
NCT03210935
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions